Retaglutide is a novel GLP-1 receptor agonist currently under research for the management of obesity. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://antonitgl166168.thekatyblog.com/37315493/trelaglutide-exploring-a-new-therapy-for-chronic-diseases